Ioverskan (Solution) Instructions for Use
Marketing Authorization Holder
Pharmasintez-Tyumen, LLC (Russia)
ATC Code
V08AB07 (Ioversol)
Active Substance
Iodine (Ph.Eur. European Pharmacopoeia)
Dosage Forms
| Ioverskan | Solution for intravenous and intra-arterial administration 240 mg iodine/1 ml: fl. 10 ml, 20 ml, 30 ml, 50 ml, 75 ml, 100 ml, 125 ml, 150 ml, 200 ml or 500 ml 1, 5 or 10 pcs. | |
| Solution for intravenous and intra-arterial administration 300 mg iodine/1 ml: fl. 10 ml, 20 ml, 30 ml, 50 ml, 75 ml, 100 ml, 125 ml, 150 ml, 200 ml or 500 ml 1, 5 or 10 pcs. | ||
| Solution for intravenous and intra-arterial administration 320 mg iodine/1 ml: fl. 10 ml, 20 ml, 30 ml, 50 ml, 75 ml, 100 ml, 125 ml, 150 ml, 200 ml or 500 ml 1, 5 or 10 pcs. | ||
| Solution for intravenous and intra-arterial administration 350 mg iodine/1 ml: fl. 10 ml, 20 ml, 30 ml, 50 ml, 75 ml, 100 ml, 125 ml, 150 ml, 200 ml or 500 ml 1, 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
Solution for intravenous and intra-arterial administration transparent, colorless or light yellow, or light yellow with a brownish tint.
| 1 ml | |
| Ioversol | 509 mg, |
| Calculated as Iodine | 240 mg |
Excipients : trometamol hydrochloride – 4.1 mg, trometamol – 0.48 mg, sodium calcium edetate – 0.2 mg, hydrochloric acid solution 1M – to pH value 6.0-7.4, water for injections – to 1 ml.
Osmolality: from 465 to 575 mOsm/kg.
Viscosity: from 4.0 to 5.3 mPa*s.
10 ml – glass bottles (1) – cardboard packs.
10 ml – glass bottles (5) – cardboard packs.
10 ml – glass bottles (10) – cardboard packs.
20 ml – glass bottles (1) – cardboard packs.
20 ml – glass bottles (5) – cardboard packs.
20 ml – glass bottles (10) – cardboard packs.
30 ml – glass bottles (1) – cardboard packs.
30 ml – glass bottles (5) – cardboard packs.
30 ml – glass bottles (10) – cardboard packs.
50 ml – glass bottles (1) – cardboard packs.
50 ml – glass bottles (5) – cardboard packs.
50 ml – glass bottles(10) – cardboard packs.
75 ml – glass bottles (1) – cardboard packs.
75 ml – glass bottles (5) – cardboard packs.
75 ml – glass bottles (10) – cardboard packs.
100 ml – glass bottles (1) – cardboard packs.
100 ml – glass bottles (5) – cardboard packs.
100 ml – glass bottles (10) – cardboard packs.
125 ml – glass bottles (1) – cardboard packs.
125 ml – glass bottles (5) – cardboard packs.
125 ml – glass bottles (10) – cardboard packs.
150 ml – glass bottles (1) – cardboard packs.
150 ml – glass bottles (5) – cardboard packs.
150 ml – glass bottles (10) – cardboard packs.
200 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (5) – cardboard packs.
200 ml – glass bottles (10) – cardboard packs.
500 ml – glass bottles (1) – cardboard packs.
500 ml – glass bottles (5) – cardboard packs.
500 ml – glass bottles (10) – cardboard packs.
Solution for intravenous and intra-arterial administration transparent, colorless or light yellow, or light yellow with a brownish tint.
| 1 ml | |
| Ioversol | 636 mg, |
| Calculated as Iodine | 300 mg |
Excipients : trometamol hydrochloride – 4.1 mg, trometamol – 0.48 mg, sodium calcium edetate – 0.2 mg, hydrochloric acid solution 1M – to pH value 6.0-7.4, water for injections – to 1 ml.
Osmolality from 580 to 705 mOsm/kg.
Viscosity from 6.0 to 8.6 mPa*s.
10 ml – glass bottles (1) – cardboard packs.
10 ml – glass bottles (5) – cardboard packs.
10 ml – glass bottles (10) – cardboard packs.
20 ml – glass bottles (1) – cardboard packs.
20 ml – glass bottles (5) – cardboard packs.
20 ml – glass bottles (10) – cardboard packs.
30 ml – glass bottles (1) – cardboard packs.
30 ml – glass bottles (5) – cardboard packs.
30 ml – glass bottles (10) – cardboard packs.
50 ml – glass bottles (1) – cardboard packs.
50 ml – glass bottles (5) – cardboard packs.
50 ml – glass bottles(10) – cardboard packs.
75 ml – glass bottles (1) – cardboard packs.
75 ml – glass bottles (5) – cardboard packs.
75 ml – glass bottles (10) – cardboard packs.
100 ml – glass bottles (1) – cardboard packs.
100 ml – glass bottles (5) – cardboard packs.
100 ml – glass bottles (10) – cardboard packs.
125 ml – glass bottles (1) – cardboard packs.
125 ml – glass bottles (5) – cardboard packs.
125 ml – glass bottles (10) – cardboard packs.
150 ml – glass bottles (1) – cardboard packs.
150 ml – glass bottles (5) – cardboard packs.
150 ml – glass bottles (10) – cardboard packs.
200 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (5) – cardboard packs.
200 ml – glass bottles (10) – cardboard packs.
500 ml – glass bottles (1) – cardboard packs.
500 ml – glass bottles (5) – cardboard packs.
500 ml – glass bottles (10) – cardboard packs.
Solution for intravenous and intra-arterial administration transparent, colorless or light yellow, or light yellow with a brownish tint.
| 1 ml | |
| Ioversol | 678 mg, |
| Calculated as Iodine | 320 mg |
Excipients : trometamol hydrochloride – 4.1 mg, trometamol – 0.48 mg, sodium calcium edetate – 0.2 mg, hydrochloric acid solution 1M – to pH value 6.0-7.4, water for injections – to 1 ml.
Osmolality from 615 to 745 mOsm/kg.
Viscosity from 7.0 to 10.5 mPa*s.
10 ml – glass bottles (1) – cardboard packs.
10 ml – glass bottles (5) – cardboard packs.
10 ml – glass bottles (10) – cardboard packs.
20 ml – glass bottles (1) – cardboard packs.
20 ml – glass bottles (5) – cardboard packs.
20 ml – glass bottles (10) – cardboard packs.
30 ml – glass bottles (1) – cardboard packs.
30 ml – glass bottles (5) – cardboard packs.
30 ml – glass bottles (10) – cardboard packs.
50 ml – glass bottles (1) – cardboard packs.
50 ml – glass bottles (5) – cardboard packs.
50 ml – glass bottles(10) – cardboard packs.
75 ml – glass bottles (1) – cardboard packs.
75 ml – glass bottles (5) – cardboard packs.
75 ml – glass bottles (10) – cardboard packs.
100 ml – glass bottles (1) – cardboard packs.
100 ml – glass bottles (5) – cardboard packs.
100 ml – glass bottles (10) – cardboard packs.
125 ml – glass bottles (1) – cardboard packs.
125 ml – glass bottles (5) – cardboard packs.
125 ml – glass bottles (10) – cardboard packs.
150 ml – glass bottles (1) – cardboard packs.
150 ml – glass bottles (5) – cardboard packs.
150 ml – glass bottles (10) – cardboard packs.
200 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (5) – cardboard packs.
200 ml – glass bottles (10) – cardboard packs.
500 ml – glass bottles (1) – cardboard packs.
500 ml – glass bottles (5) – cardboard packs.
500 ml – glass bottles (10) – cardboard packs.
Solution for intravenous and intra-arterial administration transparent, colorless or light yellow, or light yellow with a brownish tint.
| 1 ml | |
| Ioversol | 741 mg, |
| Calculated as Iodine | 350 mg |
Excipients : trometamol hydrochloride – 4.1 mg, trometamol – 0.48 mg, sodium calcium edetate – 0.2 mg, hydrochloric acid solution 1M – to pH value 6.0-7.4, water for injections – to 1 ml.
Osmolality:from 670 to 810 mOsm/kg.
Viscosity: from 10.0 to 14.6 mPa*s.
10 ml – glass bottles (1) – cardboard packs.
10 ml – glass bottles (5) – cardboard packs.
10 ml – glass bottles (10) – cardboard packs.
20 ml – glass bottles (1) – cardboard packs.
20 ml – glass bottles (5) – cardboard packs.
20 ml – glass bottles (10) – cardboard packs.
30 ml – glass bottles (1) – cardboard packs.
30 ml – glass bottles (5) – cardboard packs.
30 ml – glass bottles (10) – cardboard packs.
50 ml – glass bottles (1) – cardboard packs.
50 ml – glass bottles (5) – cardboard packs.
50 ml – glass bottles(10) – cardboard packs.
75 ml – glass bottles (1) – cardboard packs.
75 ml – glass bottles (5) – cardboard packs.
75 ml – glass bottles (10) – cardboard packs.
100 ml – glass bottles (1) – cardboard packs.
100 ml – glass bottles (5) – cardboard packs.
100 ml – glass bottles (10) – cardboard packs.
125 ml – glass bottles (1) – cardboard packs.
125 ml – glass bottles (5) – cardboard packs.
125 ml – glass bottles (10) – cardboard packs.
150 ml – glass bottles (1) – cardboard packs.
150 ml – glass bottles (5) – cardboard packs.
150 ml – glass bottles (10) – cardboard packs.
200 ml – glass bottles (1) – cardboard packs.
200 ml – glass bottles (5) – cardboard packs.
200 ml – glass bottles (10) – cardboard packs.
500 ml – glass bottles (1) – cardboard packs.
500 ml – glass bottles (5) – cardboard packs.
500 ml – glass bottles (10) – cardboard packs.
Clinical-Pharmacological Group
Radiocontrast non-ionic diagnostic agent for intravascular administration
Pharmacotherapeutic Group
Contrast agents; X-ray contrast agents containing iodine; water-soluble nephrotropic low-osmolar X-ray contrast agents
Pharmacological Action
Elemental Iodine has pronounced antimicrobial properties. Preparations of elemental iodine are characterized by a pronounced local irritant effect on tissues, and in high concentrations – a cauterizing effect. The local action is due to the ability of elemental iodine to precipitate tissue proteins. Preparations that release elemental Iodine have a much less pronounced irritant effect, and iodides have local irritant properties only in very high concentrations.
Pharmacokinetics
Upon contact with the skin or mucous membranes, 30% is converted into iodides, and the rest into active Iodine. Partially absorbed. The absorbed part penetrates into tissues and organs, selectively absorbed by the thyroid gland. It is excreted mainly by the kidneys, intestines, sweat and mammary glands.
Indications
For external use: infectious and inflammatory skin lesions, injuries, wounds, myalgia.
For topical use: chronic tonsillitis, atrophic rhinitis, purulent otitis, trophic and varicose ulcers, wounds, infected burns, fresh thermal and chemical burns of I-II degree.
ICD codes
| ICD-10 code | Indication |
| H66 | Suppurative and unspecified otitis media |
| I83.2 | Varicose veins of lower extremities with ulcer and inflammation |
| J31.0 | Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis) |
| J35.0 | Chronic tonsillitis |
| L01 | Impetigo |
| L08.0 | Pyoderma |
| L08.8 | Other specified local infections of skin and subcutaneous tissue |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| M79.1 | Myalgia |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1B72.0 | Bullous impetigo |
| 1B72.1 | Nonbullous impetigo |
| 1B72.Z | Impetigo, unspecified |
| 1B7Y | Other specified pyogenic bacterial infections of skin or subcutaneous tissue |
| 1C44 | Non-pyogenic bacterial infections of skin |
| AA9Z | Unspecified suppurative otitis media |
| BD74.Z | Chronic venous insufficiency of lower extremities, unspecified |
| CA09.0 | Chronic rhinitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| EA40 | Tropical phagedenic ulcer |
| EA50.3 | Staphylococcal scarlet fever |
| EB21 | Pyoderma gangrenosum |
| EF60 | Ischemic ulceration of the skin |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EM0Z | Unspecified skin disorder |
| FB56.2 | Myalgia |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.0 | Superficial injury of unspecified body region |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Used externally and topically.
For external use, iodine is used to treat damaged skin areas.
Topically used for washing lacunae and supratonsillar spaces, for irrigation of the nasopharynx, for instillation into the ear and washing; in surgical practice and for burns, gauze napkins applied to the affected surface are moistened as needed. Doses, method of application and duration of treatment are determined depending on the indications.
Adverse Reactions
Rarely skin irritation; with prolonged use on large surfaces – iodism (rhinitis, urticaria, angioedema, salivation, lacrimation, acne).
Contraindications
Hypersensitivity to iodine.
For external use: thyrotoxicosis, dermatitis herpetiformis.
Use in Pregnancy and Lactation
Used as indicated during pregnancy and breastfeeding.
Use in Hepatic Impairment
Used as indicated.
Use in Renal Impairment
Used as indicated.
Pediatric Use
Used as indicated.
Geriatric Use
Used as indicated.
Special Precautions
With prolonged use, phenomena of iodism are possible.
Drug Interactions
Pharmaceutically incompatible with essential oils, ammonia solutions, white precipitated mercury (forms an explosive mixture).
Alkaline or acidic environment, the presence of fat, pus, blood weaken the antiseptic activity.
Storage Conditions
Store at 2°C (36°F) to 30°C (86°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer